Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer

One TCGA subgroup of endometrial cancer (EC) is characterised by extensive genomic DNA copy number alterations. CCNE1 located at 19q12 is frequently amplified in EC and a target for anti-cancer therapy. The relevance of URI, also located at 19q12, is unknown. To evaluate the prevalence of 19q12 (CCN...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Noske, Aurelia, Brandt, Simone, Valtcheva, Nadejda, Wagner, Ulrich, Zhong, Qing, Bellini, Elisa, Fink, Daniel, Obermann, Ellen C., Moch, Holger, Wild, Peter J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362444/
https://ncbi.nlm.nih.gov/pubmed/27582547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11605
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia